BI-9667
Modify Date: 2025-08-25 19:09:39
BI-9667 structure
|
Common Name | BI-9667 | ||
|---|---|---|---|---|
| CAS Number | 1295298-26-8 | Molecular Weight | 451.47 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H18FN5O3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BI-9667CCR1 antagonist 8 (compound 19n), a third azaindazole series compound, is a CCR1 antagonist clinical candidate, with an IC50 of 1.8 nM in Ca2+ flux assay[1]. |
| Name | CCR1 antagonist 8 |
|---|
| Description | CCR1 antagonist 8 (compound 19n), a third azaindazole series compound, is a CCR1 antagonist clinical candidate, with an IC50 of 1.8 nM in Ca2+ flux assay[1]. |
|---|---|
| Related Catalog | |
| Target |
CCR1:1.8 nM (IC50, in Ca2+ flux assay) |
| References |
| Molecular Formula | C22H18FN5O3S |
|---|---|
| Molecular Weight | 451.47 |